mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.0005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.0007 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
-0.57 |
0.001 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
-0.44 |
0.002 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |